Editas Medicine, Inc is a biotechnology business based in the US. Editas Medicine shares (EDIT) are listed on the NASDAQ and all prices are listed in US Dollars. Editas Medicine employs 235 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Editas Medicine
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EDIT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Editas Medicine stock price (NASDAQ: EDIT)Use our graph to track the performance of EDIT stocks over time.
Editas Medicine shares at a glance
|Latest market close||$33.95|
|52-week range||$27.01 - $99.95|
|50-day moving average||$41.54|
|200-day moving average||$46.74|
|Wall St. target price||$44.64|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.14|
Buy Editas Medicine shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Editas Medicine stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Editas Medicine price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||-18.94%|
|3 months (2021-04-26)||-13.13%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Editas Medicine financials
|Revenue TTM||$91.5 million|
|Gross profit TTM||$-67,264,000|
|Return on assets TTM||-14.55%|
|Return on equity TTM||-30.94%|
|Market capitalisation||$2.9 billion|
TTM: trailing 12 months
Shorting Editas Medicine shares
There are currently 10.4 million Editas Medicine shares held short by investors – that's known as Editas Medicine's "short interest". This figure is 0.6% up from 10.4 million last month.
There are a few different ways that this level of interest in shorting Editas Medicine shares can be evaluated.
Editas Medicine's "short interest ratio" (SIR)
Editas Medicine's "short interest ratio" (SIR) is the quantity of Editas Medicine shares currently shorted divided by the average quantity of Editas Medicine shares traded daily (recently around 2.2 million). Editas Medicine's SIR currently stands at 4.71. In other words for every 100,000 Editas Medicine shares traded daily on the market, roughly 4710 shares are currently held short.
However Editas Medicine's short interest can also be evaluated against the total number of Editas Medicine shares, or, against the total number of tradable Editas Medicine shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Editas Medicine's short interest could be expressed as 0.15% of the outstanding shares (for every 100,000 Editas Medicine shares in existence, roughly 150 shares are currently held short) or 0.1561% of the tradable shares (for every 100,000 tradable Editas Medicine shares, roughly 156 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Editas Medicine.
Find out more about how you can short Editas Medicine stock.
Editas Medicine share dividends
We're not expecting Editas Medicine to pay a dividend over the next 12 months.
Editas Medicine share price volatility
Over the last 12 months, Editas Medicine's shares have ranged in value from as little as $27.01 up to $99.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Editas Medicine's is 1.9461. This would suggest that Editas Medicine's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Editas Medicine overview
Editas Medicine, Inc. , a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis type 10, a genetic form of vision loss that leads to blindness in childhood. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa 4, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumors; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has a early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc.
Stocks similar to Editas Medicine
Editas Medicine in the news
The Top 2 Stocks to Buy to Play the Emerging Exoskeleton Megatrend
5 Mid-Cap Healthcare Stocks You'll Want on Your Radar for the 2nd Half of 2021
Editas Medicine Stock Shows Improved Relative Strength Rating
Frequently asked questionsWhat percentage of Editas Medicine is owned by insiders or institutions?
Currently 0.248% of Editas Medicine shares are held by insiders and 77.609% by institutions. How many people work for Editas Medicine?
Latest data suggests 235 work at Editas Medicine. When does the fiscal year end for Editas Medicine?
Editas Medicine's fiscal year ends in December. Where is Editas Medicine based?
Editas Medicine's address is: 11 Hurley Street, Cambridge, MA, United States, 02141 What is Editas Medicine's ISIN number?
Editas Medicine's international securities identification number is: US28106W1036 What is Editas Medicine's CUSIP number?
Editas Medicine's Committee on Uniform Securities Identification Procedures number is: 28106W103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert